The Effects of Audiovisual Neurostimulation in women with Fibromyalgia

Not Applicable

• Conditions: Fibromyalgia; Sleep disorder; R52.2

• Registration Number: RBR-67c7n8g
• Lead Sponsor: niversidade do Sul de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-12
• Study Completion: 2022-12-29
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women with a clinical diagnosis of FM; living in the greater Florianópolis SC; aged between 18 and 80 years and undergoing pharmacological treatment.

Exclusion Criteria

Women with diseases that can be stimulated by light; with immunodepressive diseases; with oncological diseases; with infectious diseases or in a febrile state, epileptics; pregnant women; lactating women; women with symptoms or confirmation of COVID-19.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain will be assessed by EVA. The EVA consists of a horizontal line with 10 centimeters in length numbered from 0 to 10, marked at one end with the classification WITHOUT PAIN and at the other with the classification MAXIMUM PAIN. Patients will mark with a dash at the point that represents the intensity of their pain. Pain will also be assessed using the McGill questionnaire, which qualitatively and quantitatively evaluates pain. It is arranged in four categories (sensory, affective, evaluative and mixed) and 20 subcategories for them. In these words are presented with a corresponding number, qualifying and quantifying the pain. The collection will be made on the first day, after fifteen days, after thirty days, after 45 days and after 60 days of treatment.